Trial Profile
Non-interventional Study to obSERve currENtmanagement of Index Episode in Patients With Bipolar Disorder Treated bY Seroquel XR.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2010
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 16 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Mar 2010 New trial record